Adverum

Adverum Biotechnologies, Inc., wholly owned subsidiary of Eli Lilly and Company, is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prev

Adverum Biotechnologies, Inc., wholly owned subsidiary of Eli Lilly and Company, is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prev

Adverum Biotechnologies, Inc., a wholly owned subsidiary of Eli Lilly and Company, is looking for a Quality Control CTL Manager to join our team in our Redwood City office. This position reports to the Quality Control Advisor. The QC CTL Manager works in providing oversight on all QC Release and Sta

Adverum Biotechnologies, Inc., a wholly owned subsidiary of Eli Lilly and Company is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and pre

Adverum Biotechnologies, Inc., wholly owned subsidiary of Eli Lilly and Company, is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prev

Adverum Biotechnologies, Inc., wholly owned subsidiary of Eli Lilly and Company, is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prev

Adverum Biotechnologies, Inc., wholly owned subsidiary of Eli Lilly and Company, is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prev

Adverum Biotechnologies, Inc., wholly owned subsidiary of Eli Lilly and Company, is looking for a Process Development Scientist to join our team in our Redwood City office. This person will be working with teams across Analytical Development, Process Development, Quality, and Regulatory Affairs. Thi

Adverum, a wholly owned subsidiary of Eli Lilly and Company, is looking for a Scientist to join the Process Development team at our Redwood City, CA office. The individual will be responsible for executing upstream pilot -scale rAAV production and expansion protocols and procedures. This is a 12-mon

Adverum, a wholly owned subsidiary of Eli Lilly and Company, is looking for a Senior Scientist to join our Process Development team in Redwood City. This individual will be a key member of the team, focusing on downstream activities. This is a 12-month contract with an opportunity for an extension.

Adverum Biotechnologies, Inc., wholly owned subsidiary of Eli Lilly and Company, is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prev

Adverum Biotechnologies, Inc., wholly owned subsidiary of Eli Lilly and Company, is looking to bring on board a Clinical Scientist/Senior (Contract). This role will support the assigned Clinical Trial Lead with the design and execution of key elements of the Clinical Development Plan (clinical study

Adverum Biotechnologies, Inc., a wholly owned subsidiary of Eli Lilly and Company is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and pre

Adverum is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the capabilities of its proprietary intravitreal platform, Adv